As columnist Mary Shaniqua looks to the future, she remembers when she was far more active — and wonders if that could be a ...
The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle ...
With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback